Metformin Reverses Lymphatic Damage From Chemotherapy
Researchers found that the medication may protect lymphatic cells from damage caused by the common chemotherapy drug 5-Fluorouracil.
Updated on Oct. 11, 2026 in Heart Disease
Live Poll
Is repurposing existing medications for new health conditions a beneficial approach for medical progress?
A new study has revealed that metformin can counteract damage to the lymphatic system induced by 5-Fluorouracil chemotherapy. This discovery offers potential insights into managing secondary lymphedema for patients undergoing these specific cancer treatments.
Why it matters
Secondary lymphedema is a common complication that can significantly impact the quality of life for cancer survivors. Investigating how existing medications like metformin protect lymphatic function may eventually lead to new strategies for mitigating this side effect during treatment.
This preclinical study utilized a mouse model to demonstrate that metformin protects lymphatic endothelial cells from chemotherapy-induced injury. Findings showed that the drug restored normal gene expression and mitochondrial function, although these are preliminary results.
The details
Chemotherapy with 5-Fluorouracil often triggers mitochondrial superoxide accumulation, which impairs the energy-producing capacity of lymphatic endothelial cells. Metformin works by restoring the expression of vital genes like Gata2, Foxc2, and Sox18, which are critical for lymphatic health. By reducing oxidative stress and restoring cellular ATP production, the medication prevents the characteristic dermal thickening and limb volume increases associated with lymphedema.
Timeline
October 11, 2026: Research findings regarding metformin and lymphatic system protection were published.
Health Landscape
This study contributes to the growing scientific interest in repurposing established metabolic medications to mitigate chemotherapy-related toxicities. It builds on a landscape where researchers are increasingly looking for ways to protect healthy tissues without compromising the anti-cancer efficacy.
These findings are limited to preclinical models and do not currently change clinical practice or treatment protocols. Anyone experiencing swelling or skin changes during or after chemotherapy should consult their oncology team to discuss appropriate monitoring and supportive care.
The takeaway
Metformin may help prevent lymphatic system damage caused by 5-Fluorouracil, representing a new area of study for supportive cancer care. If you are undergoing chemotherapy, continue to track any new swelling and discuss any concerns about long-term side effects with your physician.
Further reading
For more on maintaining vascular and systemic health, visit our Heart Disease section.
More information
Review the detailed findings in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
Live Poll
Is repurposing existing medications for new health conditions a beneficial approach for medical progress?
